Shanghai Jiaoda Onlly Co.,Ltd (SHA:600530)
5.31
-0.14 (-2.57%)
At close: Mar 20, 2026
SHA:600530 Revenue
Shanghai Jiaoda Onlly Co.,Ltd had revenue of 73.69M CNY in the quarter ending September 30, 2025, a decrease of -4.16%. This brings the company's revenue in the last twelve months to 312.75M, up 10.66% year-over-year. In the year 2024, Shanghai Jiaoda Onlly Co.,Ltd had annual revenue of 325.18M with 9.74% growth.
Revenue (ttm)
312.75M
Revenue Growth
+10.66%
P/S Ratio
13.16
Revenue / Employee
342.92K
Employees
912
Market Cap
4.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 325.18M | 28.85M | 9.74% |
| Dec 31, 2023 | 296.33M | -80.82M | -21.43% |
| Dec 31, 2022 | 377.15M | 14.57M | 4.02% |
| Dec 31, 2021 | 362.58M | 29.88M | 8.98% |
| Dec 31, 2020 | 332.70M | 92.83K | 0.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Starry Pharmaceutical | 2.39B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| LanZhou Foci Pharmaceutical | 895.75M |
| Qianjiang Yongan Pharmaceutical | 797.25M |
| Tibet AIM Pharm. | 628.02M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |
| Shanghai Xiao Fang Pharmaceutical | 504.59M |